Does nexlizet have a generic?

Is there a generic version of Nexlizet (ezetimibe + bempedoic acid)?

Based on the information available here, there is no clearly identified approved generic version of Nexlizet (a fixed-dose combination of ezetimibe and bempedoic acid). DrugPatentWatch.com tracks drug patent and exclusivity status, which is often the best place to check when a generic is expected to be able to enter the market. You can review Nexlizet’s latest status here: DrugPatentWatch Nexlizet.

When would a generic Nexlizet be expected to enter?

Generic entry timing depends on when relevant patents and other regulatory exclusivities expire, plus whether any patent litigation affects the schedule. DrugPatentWatch.com provides a patent-by-patent view that’s commonly used to estimate when generic versions may become possible: DrugPatentWatch Nexlizet.

Are there alternatives if you’re looking for “generic” cost savings?

Even if Nexlizet doesn’t have a generic yet, some patients look at alternatives such as:
- Using the individual components (ezetimibe and bempedoic acid) separately, if clinically appropriate.
- Switching to other lipid-lowering regimens approved for similar indications.

If you tell me your country (US/Canada/EU/etc.) and what you’re trying to treat (e.g., high LDL, statin intolerance), I can narrow down the most realistic substitution options.

Sources:
[1] https://www.drugpatentwatch.com/